News Digging > Popular > IU Cancer Center Researcher Leads First In-Human Multiple Myeloma Study with 90.5% Response Rate
IU Cancer Center Researcher Leads First In-Human Multiple Myeloma Study with 90.5% Response Rate
IU Cancer Center Researcher Leads First In-Human Multiple Myeloma Study with 90.5% Response Rate,INDIANAPOLIS—Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical

IU Cancer Center Researcher Leads First In-Human Multiple Myeloma Study with 90.5% Response Rate

INDIANAPOLIS—Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical